is recognized as an international leader in the field of obesity medicine
While the oral semaglutide formulation Rybelsus has been available for type 2 diabetes, Wegovy as a pill represents the first FDA-approved oral option for obesity, offering patients an alternative to injections and potentially improving long-term treatment adherence
Semaglutide stimulates the release of insulin from pancreatic beta cells, reduces glucagon secretion from the liver, slows down gastric emptying, and promotes satiety
2 4 5 As GSH levels decline with age and stress, replenishing them may help give the brain more of what it naturally uses to stay sharp
While estrogen and cortisol are not standard lab tests for patients taking GLP-1 medications (unless the patient has pre-existing conditions like PCOS or an adrenal disorder or is exhibiting specific symptoms), there is a growing body of research that indicates the drugs can affect and interact with these hormones, especially in certain patient populations, like women navigating menopause